Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
Z83tSgker0evDsAq
